Catabasis Pharmaceuticals, Inc. CATB
Set alert
8.54 0.00 0.00%
At close
8.48 Day range 9.21
52-week range unavailable
- Open
- 10.07
- Prev close
- 8.54
- Mkt cap
- 234.86M
- Vol
- 98.87K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.48
- High
- 9.21
- Forward P/E
- -2.81
- Beta
- 1.66
- Short ratio
- 0.87
- Inst. own
- 55.08%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 9, 2021
- 50-d avg
- 8.23
- 200-d avg
- 3.74
- 1y target
- 23.00
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 23.00 +169.3% upside
Now 8.54
- Target (low)
- 13.00
- Target (mean)
- 23.00
- Target (high)
- 36.00
Ratings (0m) 5 3 buy · 2 hold · 0 sell
- Strong buy2
- Buy1
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 4
- 2 months ago 3
- 3 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.77 | -1.14 – -0.64 | -3.36 | +77.1% | 0 | 0.0% | 4 |
| Next quarter | -0.86 | -1.26 – -0.63 | -2.64 | +67.4% | 0 | 0.0% | 4 |
| Current year | -33.61 | -52.20 – -22.20 | -12.18 | -175.9% | 0 | 0.0% | 4 |
| Next year | -3.04 | -3.90 – -2.45 | -33.61 | +91.0% | 0 | 0.0% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 2, 2021 | Wedbush | Initiated | — | Outperform |
| Aug 25, 2021 | HC Wainwright & Co. | Upgrade | Neutral | Buy |
| May 12, 2021 | Ladenburg Thalmann | Initiated | — | Buy |
| Mar 11, 2021 | Oppenheimer | Upgrade | Perform | Outperform |
| Nov 25, 2020 | HC Wainwright & Co. | Initiated | — | Buy |
| Nov 25, 2020 | Citigroup | Maintained | Buy | Buy |
| Nov 25, 2020 | Wedbush | Maintained | Outperform | Outperform |
| Nov 25, 2020 | Citigroup | Upgrade | Neutral | Buy |
| Nov 25, 2020 | Citigroup | Maintained | — | Neutral |
| Nov 25, 2020 | Citigroup | Downgrade | Buy | Neutral |
| Nov 25, 2020 | Citigroup | Maintained | — | Buy |
| Nov 25, 2020 | Citigroup | Initiated | — | Buy |
| Nov 25, 2020 | Oppenheimer | Initiated | — | Outperform |
| Nov 25, 2020 | Wedbush | Initiated | — | Outperform |
| Nov 25, 2020 | Cowen & Co. | Initiated | — | Outperform |
| Nov 25, 2020 | Citigroup | Maintained | — | Buy |
| Nov 2, 2020 | Wedbush | Downgrade | Outperform | Neutral |
| Oct 27, 2020 | Oppenheimer | Downgrade | Outperform | Perform |
| Oct 27, 2020 | HC Wainwright & Co. | Downgrade | Buy | Neutral |